CorMedix Historical Valuation

CRMD Stock  USD 8.57  0.30  3.38%   
Some fundamental drivers such as market cap or CorMedix enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze CorMedix valuation indicators such as Working Capital of 0.0 or Enterprise Value of 155.8 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of CorMedix's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.

About CorMedix Valuation Data Analysis

Valuation is the financial process of determining what CorMedix is worth. CorMedix valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. CorMedix valuation ratios help investors to determine whether CorMedix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CorMedix with respect to the benefits of owning CorMedix security.

CorMedix Valuation Data Chart

The current year's Market Cap is expected to grow to about 201 M. The current year's Enterprise Value is expected to grow to about 155.8 M

Enterprise Value

Enterprise Value (or EV) is usually referred to as CorMedix theoretical takeover price. In the event of an acquisition, an acquirer would have to take on CorMedix debt, but would also pocket its cash. Enterprise Value is more accurate representation of CorMedix value than its market capitalization because it takes into account all of CorMedix existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.212
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.38)
Return On Equity
(0.65)
The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.